Recombinant V-Erb B2 Erythroblastic Leukemia Viral Oncogene Homolog 3 (ErbB3)

HER3; MDA-BF-1; C-ErbB3; LCCS2; ErbB3-S; P180-ErbB3; P45-SErbB3; P85-SErbB3; Receptor Tyrosine-Protein Kinase ErbB-3; Lethal Congenital Contracture Syndrome 2

  • Recombinant V-Erb B2 Erythroblastic Leukemia Viral Oncogene Homolog 3 (ErbB3) Packages (Simulation)
  • Recombinant V-Erb B2 Erythroblastic Leukemia Viral Oncogene Homolog 3 (ErbB3) Packages (Simulation)
  • RPC187Mu01.jpg SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

SEQUENCE of the Recombinant V-Erb B2 Erythroblastic Leukemia Viral Oncogene Homolog 3 (ErbB3)

USAGE of the Recombinant V-Erb B2 Erythroblastic Leukemia Viral Oncogene Homolog 3 (ErbB3)

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

STORAGE of the Recombinant V-Erb B2 Erythroblastic Leukemia Viral Oncogene Homolog 3 (ErbB3)

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY of the Recombinant V-Erb B2 Erythroblastic Leukemia Viral Oncogene Homolog 3 (ErbB3)

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

GUESTBOOK